Your browser doesn't support javascript.
loading
Advantage of ostarine over raloxifene and their combined treatments for muscle of estrogen-deficient rats.
Roch, P J; Noisser, L; Böker, K O; Hoffmann, D B; Schilling, A F; Sehmisch, S; Komrakova, M.
Affiliation
  • Roch PJ; Department of Trauma Surgery, Orthopaedics and Plastic Surgery, University of Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany. jonathan.roch@med.uni-goettingen.de.
  • Noisser L; Department of Trauma Surgery, Orthopaedics and Plastic Surgery, University of Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
  • Böker KO; Department of Trauma Surgery, Orthopaedics and Plastic Surgery, University of Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
  • Hoffmann DB; Department of Trauma Surgery, Orthopaedics and Plastic Surgery, University of Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
  • Schilling AF; Department of Trauma Surgery, Orthopaedics and Plastic Surgery, University of Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
  • Sehmisch S; Department of Trauma Surgery, Orthopaedics and Plastic Surgery, University of Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
  • Komrakova M; Department of Trauma Surgery, Hannover Medical School, University of Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
J Endocrinol Invest ; 47(3): 709-720, 2024 Mar.
Article in En | MEDLINE | ID: mdl-37672168
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Complementary Medicines: Homeopatia Main subject: Insulin-Like Growth Factor I / Raloxifene Hydrochloride / Anilides Type of study: Prognostic_studies Language: En Journal: J Endocrinol Invest Year: 2024 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Complementary Medicines: Homeopatia Main subject: Insulin-Like Growth Factor I / Raloxifene Hydrochloride / Anilides Type of study: Prognostic_studies Language: En Journal: J Endocrinol Invest Year: 2024 Type: Article Affiliation country: Germany